Total Payments
$366,833
2024 Payments
$5,000
Companies
17
Transactions
275
Payment Breakdown by Category
Consulting$174,578 (47.6%)
Other$136,565 (37.2%)
Travel$48,462 (13.2%)
Food & Beverage$7,183 (2.0%)
Education$45.31 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $174,578 | 37 | 47.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $99,202 | 31 | 27.0% |
| Travel and Lodging | $48,462 | 99 | 13.2% |
| Honoraria | $37,363 | 8 | 10.2% |
| Food and Beverage | $7,183 | 95 | 2.0% |
| Education | $45.31 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOVERATIV THERAPEUTICS INC. | $71,246 | 27 | $0 (2020) |
| Genentech USA, Inc. | $57,191 | 36 | $0 (2023) |
| Spark Therapeutics, Inc. | $42,305 | 43 | $0 (2022) |
| Shire North American Group Inc | $39,495 | 41 | $0 (2019) |
| CSL Behring | $37,957 | 23 | $0 (2022) |
| PFIZER INC. | $30,045 | 16 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $22,678 | 34 | $0 (2019) |
| GENZYME CORPORATION | $20,170 | 11 | $0 (2022) |
| Novo Nordisk Inc | $17,655 | 13 | $0 (2019) |
| Genentech, Inc. | $13,352 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,000 | 2 | PFIZER INC. ($5,000) |
| 2023 | $16,019 | 9 | Genentech USA, Inc. ($9,567) |
| 2022 | $48,227 | 26 | Genentech USA, Inc. ($17,564) |
| 2021 | $39,755 | 23 | Spark Therapeutics, Inc. ($10,781) |
| 2020 | $50,712 | 30 | BIOVERATIV THERAPEUTICS INC. ($27,265) |
| 2019 | $90,584 | 60 | BIOVERATIV THERAPEUTICS INC. ($33,796) |
| 2018 | $66,379 | 54 | CSL Behring ($18,981) |
| 2017 | $50,156 | 71 | Shire North American Group Inc ($13,515) |
All Payment Transactions
275 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/28/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 05/28/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 11/16/2023 | Genentech USA, Inc. | Hemlibra (Biological) | Consulting Fee | Cash or cash equivalent | $8,740.00 | General |
| Category: Hematology | ||||||
| 11/16/2023 | Genentech USA, Inc. | Hemlibra (Biological) | Travel and Lodging | Cash or cash equivalent | $512.52 | General |
| Category: Hematology | ||||||
| 11/16/2023 | Genentech USA, Inc. | Hemlibra (Biological) | Travel and Lodging | Cash or cash equivalent | $242.65 | General |
| Category: Hematology | ||||||
| 11/16/2023 | Genentech USA, Inc. | Hemlibra (Biological) | Travel and Lodging | Cash or cash equivalent | $44.00 | General |
| Category: Hematology | ||||||
| 11/16/2023 | Genentech USA, Inc. | Hemlibra (Biological) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: Hematology | ||||||
| 09/18/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 04/24/2023 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 03/16/2023 | BioMarin Pharmaceutical Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,880.00 | General |
| 03/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $72.00 | General |
| 11/12/2022 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $8,991.00 | General |
| 11/12/2022 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $462.82 | General |
| 11/12/2022 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $402.67 | General |
| 11/12/2022 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $159.85 | General |
| 11/12/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $63.30 | General |
| 11/12/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $51.30 | General |
| 11/12/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $45.30 | General |
| 11/11/2022 | Genentech USA, Inc. | HEMLIBRA (Biological) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: Hematology | ||||||
| 11/10/2022 | Genentech USA, Inc. | HEMLIBRA (Biological) | Consulting Fee | Cash or cash equivalent | $8,740.00 | General |
| Category: Hematology | ||||||
| 11/10/2022 | Genentech USA, Inc. | HEMLIBRA (Biological) | Travel and Lodging | In-kind items and services | $465.41 | General |
| Category: Hematology | ||||||
| 11/10/2022 | Genentech USA, Inc. | HEMLIBRA (Biological) | Travel and Lodging | In-kind items and services | $336.66 | General |
| Category: Hematology | ||||||
| 11/10/2022 | Genentech USA, Inc. | HEMLIBRA (Biological) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: Hematology | ||||||
| 11/10/2022 | Genentech USA, Inc. | HEMLIBRA (Biological) | Travel and Lodging | Cash or cash equivalent | $81.57 | General |
| Category: Hematology | ||||||
| 09/26/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
About Dr. Shannon Meeks, MD
Dr. Shannon Meeks, MD is a Pediatric Hematology-Oncology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275615502.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shannon Meeks, MD has received a total of $366,833 in payments from pharmaceutical and medical device companies, with $5,000 received in 2024. These payments were reported across 275 transactions from 17 companies. The most common payment nature is "Consulting Fee" ($174,578).
Ad
Practice Information
- Specialty Pediatric Hematology-Oncology
- Location Atlanta, GA
- Active Since 10/19/2006
- Last Updated 06/06/2022
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1275615502
Products in Payments
- HEMLIBRA (Biological) $49,857
- ELOCTATE (Biological) $26,735
- NO PRODUCT DISCUSSED (Drug) $17,164
- ELOCTATE (Drug) $16,632
- Non-Covered Product (Drug) $13,353
- Hemlibra (Biological) $9,567
- Jivi (Drug) $8,115
- Non-Covered $7,522
- NUWIQ (Biological) $7,102
- Kovaltry (Drug) $7,041
- Afstyla (Biological) $5,556
- Idelvion (Biological) $1,661
- CEPROTIN (Biological) $1,188
- FEIBA (Biological) $415.00
- RHOGAM (Drug) $72.81
- BENEFIX (Biological) $45.31
- Alphanate (Biological) $38.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Atlanta
Robert Sidonio, Md, MD
Pediatric Hematology-Oncology — Payments: $898,589
Pediatric Hematology-Oncology $898,589
Bhavya Doshi, M.d, M.D
Pediatric Hematology-Oncology — Payments: $177,468
Pediatric Hematology-Oncology $177,468
Vivien Sheehan, Md, MD
Pediatric Hematology-Oncology — Payments: $100,331
Pediatric Hematology-Oncology $100,331
Muna Qayed, Md, MD
Pediatric Hematology-Oncology — Payments: $76,871
Pediatric Hematology-Oncology $76,871
Carlton Dampier, Md, MD
Pediatric Hematology-Oncology — Payments: $72,327
Pediatric Hematology-Oncology $72,327
Shanmuganathan Chandrakasan, Md, MD
Pediatric Hematology-Oncology — Payments: $43,728
Pediatric Hematology-Oncology $43,728